208 related articles for article (PubMed ID: 33652881)
1. Senescence Marker Protein 30 (SMP30): A Novel Pan-Species Diagnostic Marker for the Histopathological Diagnosis of Breast Cancer in Humans and Animals.
Baek SM; Lee SW; Kim TU; Choi SK; Yun S; Lee WJ; Han SH; Hong IH; Park SJ; Kim TH; Jeong KS; Park JK
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33652881
[TBL] [Abstract][Full Text] [Related]
2. Prognostic studies of canine and feline mammary tumours: the need for standardized procedures.
Matos AJ; Baptista CS; Gärtner MF; Rutteman GR
Vet J; 2012 Jul; 193(1):24-31. PubMed ID: 22296767
[TBL] [Abstract][Full Text] [Related]
3. 3, 3'5 Triiodo L thyronine induces apoptosis in human breast cancer MCF-7 cells, repressing SMP30 expression through negative thyroid response elements.
Sar P; Peter R; Rath B; Das Mohapatra A; Mishra SK
PLoS One; 2011; 6(6):e20861. PubMed ID: 21687737
[TBL] [Abstract][Full Text] [Related]
4. Expression profile of saccharide epitope CaMBr1 in normal and neoplastic tissue from dogs, cats, and rats: implication for the development of human-derived cancer vaccines.
Adobati E; Zacchetti A; Perico ME; Cremonesi F; Rasi G; Vallebona PS; Hagenaars M; Kuppen PJ; Pastan I; Panza L; Russo G; Colnaghi MI; Canevari S
Histochem J; 1999 Nov; 31(11):729-37. PubMed ID: 10646838
[TBL] [Abstract][Full Text] [Related]
5. Thyroglobulin as a negative marker for malignancy in canine and human breast tumors.
Hwang SH; Yang Y; Woo SH; Jung JH; Seo D; Kim DY; Kim Y
Mol Carcinog; 2021 Jul; 60(7):455-468. PubMed ID: 34003526
[TBL] [Abstract][Full Text] [Related]
6. Senescence marker protein 30 (SMP30) serves as a potential prognostic indicator in hepatocellular carcinoma.
Mo Z; Zheng S; Lv Z; Zhuang Y; Lan X; Wang F; Lu X; Zhao Y; Zhou S
Sci Rep; 2016 Dec; 6():39376. PubMed ID: 27991558
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of cyclin A, cyclin D1 and P53 in mammary tumors, squamous cell carcinomas and basal cell tumors of dogs and cats.
Murakami Y; Tateyama S; Rungsipipat A; Uchida K; Yamaguchi R
J Vet Med Sci; 2000 Jul; 62(7):743-50. PubMed ID: 10945293
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology and classification for canine and feline mammary gland tumors: a histopathological survey of 437 mammary gland tumor biopsies performed in a secondary care hospital in Chiang Mai, Thailand from 2012 to 2019.
Srisawat W; Pringproa K; Prachasilchai W; Thongtharb A; Sthitmatee N
PeerJ; 2024; 12():e17077. PubMed ID: 38500523
[TBL] [Abstract][Full Text] [Related]
9. Preliminary investigation of extracellular vesicles in mammary cancer of dogs and cats: Identification and characterization.
Sammarco A; Finesso G; Cavicchioli L; Ferro S; Caicci F; Zanetti R; Sacchetto R; Zappulli V
Vet Comp Oncol; 2018 Dec; 16(4):489-496. PubMed ID: 29851284
[TBL] [Abstract][Full Text] [Related]
10. First description of feline inflammatory mammary carcinoma: clinicopathological and immunohistochemical characteristics of three cases.
Pérez-Alenza MD; Jiménez A; Nieto AI; Peña L
Breast Cancer Res; 2004; 6(4):R300-7. PubMed ID: 15217496
[TBL] [Abstract][Full Text] [Related]
11. Activation of AKT in feline mammary carcinoma: a new prognostic factor for feline mammary tumours.
Maniscalco L; Iussich S; de Las Mulas JM; Millán Y; Biolatti B; Sasaki N; Nakagawa T; De Maria R
Vet J; 2012 Jan; 191(1):65-71. PubMed ID: 21282070
[TBL] [Abstract][Full Text] [Related]
12. Immunocytochemical study of Ki-67 as a prognostic marker in canine mammary neoplasia.
Zuccari DA; Santana AE; Cury PM; Cordeiro JA
Vet Clin Pathol; 2004; 33(1):23-8. PubMed ID: 15048623
[TBL] [Abstract][Full Text] [Related]
13. Reduced PTEN protein expression and its prognostic implications in canine and feline mammary tumors.
Ressel L; Millanta F; Caleri E; Innocenti VM; Poli A
Vet Pathol; 2009 Sep; 46(5):860-8. PubMed ID: 19429983
[TBL] [Abstract][Full Text] [Related]
14. One-year conditional survival of dogs and cats with invasive mammary carcinomas: A concept inspired from human breast cancer.
Chocteau F; Mordelet V; Dagher E; Loussouarn D; Abadie J; Nguyen F
Vet Comp Oncol; 2021 Mar; 19(1):140-151. PubMed ID: 32954630
[TBL] [Abstract][Full Text] [Related]
15. Metallothionein expression in canine and feline mammary and melanotic tumours.
Dincer Z; Jasani B; Haywood S; Mullins JE; Fuentealba IC
J Comp Pathol; 2001; 125(2-3):130-6. PubMed ID: 11578128
[TBL] [Abstract][Full Text] [Related]
16. Expression levels of the focal adhesion-associated proteins paxillin and p130CAS in canine and feline mammary tumors.
Scibelli A; d'Angelo D; Pelagalli A; Tafuri S; Avallone L; Della Morte R; Staiano N
Vet Res; 2003; 34(2):193-202. PubMed ID: 12657211
[TBL] [Abstract][Full Text] [Related]
17. Expression of Tumour Endothelial Marker 8 in Canine Mammary Gland Tumour Cells.
Noguchi S; Araki M; Nakajima K; Koh M; Kokado Y; Kubo Y; Otsuka H; Yasuda A; Yokosuka M; Soeta S
J Comp Pathol; 2019 Nov; 173():30-40. PubMed ID: 31812171
[TBL] [Abstract][Full Text] [Related]
18. Advancing canine mammary tumor diagnostics: Unraveling the diagnostic potential of Cytokeratin 19 through droplet digital PCR analysis.
Tanvetthayanont P; Yata T; Boonnil J; Temisak S; Ponglowhapan S
Theriogenology; 2024 Mar; 217():127-135. PubMed ID: 38271766
[TBL] [Abstract][Full Text] [Related]
19. [Localization of senescence marker protein-30 (SMP30) in the mouse submandibular gland and histological findings in the SMP30 knock-out mouse].
Ishii K; Abe K; Tsubaki K; Yamamoto M; Akita M; Ishigami A; Maruyama N
Nihon Jibiinkoka Gakkai Kaiho; 2002 Sep; 105(9):915-9. PubMed ID: 12400167
[TBL] [Abstract][Full Text] [Related]
20. Pathological and Immunohistochemical Microscopy of Natural Cases of Canine and Feline Neoplastic Mammary Lesions.
Tawfik MF; Oda SS; Khafaga AF
Microsc Microanal; 2021 Aug; 27(4):910-922. PubMed ID: 34128458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
